Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Bernstein

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma modelC C Badger, D S Wilbur, S W Hadley, et al.
Blood|February 1, 1996
Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangementsF G Behm, F O Smith, S C Raimondi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Inhibition of granulocytic differentiation by mNotch1L A Milner, A Bigas, R Kopan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1987
Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclassC Anasetti, P J Martin, Y Morishita, et al.
Blood|July 1, 1992
Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factorV C Broudy, F O Smith, N Lin, et al.
Medical and Pediatric Oncology|January 1, 1979
Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLLR L Baehner, I D Bernstein, H Sather, et al.
Cancer Treatment Reports|August 1, 1978
Phase II study of the failure of vincristine and bleomycin for previously treated children with metastatic neuroblastoma: a report from the Childrens Cancer Study GroupI D Bernstein, A E Evans, J Finklestein, et al.
Blood|November 1, 1986
The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursorsR G Andrews, M Takahashi, G M Segal, et al.
Cancer Research|August 1, 1988
Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomasT Y Basham, M A Palladino, C C Badger, et al.
Blood|January 13, 1999
Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant modelsD C Matthews, P J Martin, C Nourigat, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma modelC C Badger, D S Wilbur, S W Hadley, et al.
Blood|February 1, 1996
Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangementsF G Behm, F O Smith, S C Raimondi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Inhibition of granulocytic differentiation by mNotch1L A Milner, A Bigas, R Kopan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1987
Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclassC Anasetti, P J Martin, Y Morishita, et al.
Blood|July 1, 1992
Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factorV C Broudy, F O Smith, N Lin, et al.
Medical and Pediatric Oncology|January 1, 1979
Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLLR L Baehner, I D Bernstein, H Sather, et al.
Cancer Treatment Reports|August 1, 1978
Phase II study of the failure of vincristine and bleomycin for previously treated children with metastatic neuroblastoma: a report from the Childrens Cancer Study GroupI D Bernstein, A E Evans, J Finklestein, et al.
Blood|November 1, 1986
The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursorsR G Andrews, M Takahashi, G M Segal, et al.
Cancer Research|August 1, 1988
Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomasT Y Basham, M A Palladino, C C Badger, et al.
Blood|January 13, 1999
Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant modelsD C Matthews, P J Martin, C Nourigat, et al.
Pageof 13